U.S., Aug. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07746375) titled 'Talking Circle for Native American Youth Living Well (AYoLi)' on July 29. Brief Summary: Th... और पढ़ें
U.S., Aug. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07746414) titled 'Effects of Exercise Prior to Radical Prostatectomy' on July 29. Brief Summary: This pilot s... और पढ़ें
Singapore, Aug. 6 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Investigator- and Participant-Blinded, Placebo-Controlled, Randomized, Multiple-Dose Stu... और पढ़ें
U.S., Aug. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07746921) titled 'Smart Inhaler and Remote Asthma Management in Adolescents With Intellectual and Developmenta... और पढ़ें
Singapore, Aug. 6 -- The Health Sciences Authority received information related to the study titled 'A Phase 1 randomized, double-blind, placebo-controlled, single-ascending-dose study investigating t... और पढ़ें
Singapore, Aug. 6 -- The Health Sciences Authority received information related to the study titled 'A Multinational, Multicenter Study With an Open-Label Phase 1b and a Randomized, Double-Blind, Plac... और पढ़ें
Singapore, Aug. 6 -- The Health Sciences Authority received information related to the study titled 'A Global, Multicenter, Prospective, Controlled, Open-Label Pivotal Study of Iodofalan (131I) Soluti... और पढ़ें
U.S., Aug. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07748052) titled 'Strength Training Combined With Blood Flow Restriction and Cerebral Palsy' on July 30. Brie... और पढ़ें
Singapore, Aug. 6 -- The Health Sciences Authority received information related to the study titled 'RASolute 303: A Phase 3 Global, Multicenter, Open-label, Randomized, 3-Arm Study of Daraxonrasib Mo... और पढ़ें
Singapore, Aug. 6 -- The Health Sciences Authority received information related to the study titled 'RASolute 303: A Phase 3 Global, Multicenter, Open-label, Randomized, 3-Arm Study of Daraxonrasib Mo... और पढ़ें